期刊
JOURNAL OF CONTROLLED RELEASE
卷 286, 期 -, 页码 85-93出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2018.07.031
关键词
Lipoplexes; Leukocyte uptake; Gene delivery; PEGylation
资金
- ALSAM Foundation
- National Institutes of Health [RO1EB016378, R01NS094758/P01AG032958]
- University of Colorado Cancer Center via NIH [P30CA046934]
Decades of research into improving drug delivery to tumors has documented uptake of particulate delivery systems by resident macrophages in the lung, liver, and spleen, and correlated short circulation times with reduced tumor accumulation. An implicit assumption in these studies is that nanoparticles present in the blood are available for distribution to the tumor. This study documents significant levels of lipoplex uptake by circulating leukocytes, and its effect on distribution to the tumor and other organs. In agreement with previous studies, PEGylation dramatically extends circulation times and enhances tumor delivery. However, our studies suggest that this relationship is not straightforward, and that particle sequestration by leukocytes can significantly alter biodistribution, especially with non-PEGylated nanoparticle formulations. We conclude that leukocyte uptake should be considered in biodistribution studies, and that delivery to these circulating cells may present opportunities for treating viral infections and leukemia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据